Integrated Safety Analysis of Abrocitinib in 635 Adolescent Patients With Moderate-To-Severe Atopic Dermatitis With Over 1000 Patient-Years of Exposure. J of Skin [Internet]. 2024 Mar. 18 [cited 2025 Apr. 18];8(2):s379. Available from: https://skin.dermsquared.com/skin/article/view/2690